This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Eye Vitamin Pioneer Offers Dry Eye Relief Guarantee

ST. LOUIS, Sept. 26, 2013 /PRNewswire/ -- ZeaVision® the parent company of EyePromise eye vitamins has introduced a new 30-day money-back guarantee for their dry eye and contact lens comfort formula, EyePromise EZ Tears.

(Photo: http://photos.prnewswire.com/prnh/20130926/PH87553 )

Based upon the outstanding results of recent clinical trials in subjects with dry eye and contact lens discomfort, EyePromise EZ Tears is now backed by a 30-day money-back guarantee!  Terry Sullivan, Vice President, Sales and Marketing for ZeaVision explains, "Based upon EZ Tears clinical study results wherein more than 50% of patients reported relief in two weeks, and more than 85% in four weeks, ZeaVision confidently announces the first money-back guarantee in the dry eye category!  This bold position demonstrates that ZeaVision believes in and stands behind its products and customers."

EZ Tears is a doctor-recommended, science-based nutraceutical designed to help patients suffering from dry eye and contact lens discomfort by supporting healthy tear film composition and ocular surface health.  Dry eye affects up to 40-million Americans, or one in five people, leading to symptoms like burning, scratching, the sensation of a foreign particle in the eye, redness, and even excessive reflex watering. These symptoms tend to intensify during winter months as humidity levels drop and home heating systems are activated, resulting in drier air.

The EyePromise EZ Tears formula features eight ingredients and more than 1,000 mgs of EPA/DHA Omega-3 essential fatty acids to support healthy tear production and comfortable eyes.  Other ingredients like Vitamin A Retinyl Palmitate, Vitamin D3, Vitamin E, Evening Primrose Oil, Turmeric Extract, and Green Tea Extract also support ocular health.

For more information on EyePromise EZ Tears, or any of the EyePromise brand nutraceuticals, visit the company's website at www.eyepromise.com/eztears.

About ZeaVision

ZeaVision®, the parent company of EyePromise®, is passionate about fighting vision loss and preserving healthy vision through ocular nutrition. With over 20 years of research, ZeaVision pioneered the use of Zeaxanthin, a natural antioxidant and photo-protectant, for eye health use. EyePromise science-based nutraceuticals offer the highest levels of dietary Zeaxanthin available, and are developed for patients suffering from dry eye symptoms and those at risk for AMD.  With more than 40-million doses consumed, EyePromise products are made in the U.S.A from the highest-quality, natural ingredients. Contact ZeaVision today at 866.833.2800, or support@eyepromise.com.

ZeaVision ®, EyePromise ®, QuantifEye ®, and Eye-Q™ are the respective logos and registered trademarks of ZeaVision, LLC. All other trademarks herein are properties of their respective owners. All rights reserved.                                                                                   

Contact: Dana HoffmanMarketing ManagerZeaVision, LLC (866) 833-2800 Email www.eyepromise.com

Read more news from ZeaVision

SOURCE ZeaVision

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,918.71 -41.86 -0.25%
S&P 500 1,971.01 -7.33 -0.37%
NASDAQ 4,423.6240 -25.94 -0.58%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs